美芝股份(002856.SZ):擬向關聯方申請不超2000萬元借款額度
格隆匯9月22日丨美芝股份(002856.SZ)公佈,公司於2021年9月18日召開第四屆董事會第九次會議和第四屆監事會第九次會議,審議通過了《關於向關聯方借款暨關聯交易的議案》。
為更好地促進公司業務發展,公司擬向關聯方廣東萬向維景建設工程發展有限公司申請總額不超過人民幣2000萬元的借款額度,借款期限自董事會審議通過之日起一年,借款利率不超過一年期貸款基準利率。
公司根據實際資金需求量在借款額度內支取,循環使用,利息支付根據借款實際使用天數和借款年利率計算,並授權公司經營管理層具體負責實施該次交易事項。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.